Navigation Links
Align Technology Announces Fourth Quarter and Fiscal 2008 Results
Date:1/28/2009

statements for any reason.



    ALIGN TECHNOLOGY, INC.
    UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
    (in thousands, except per share data)


                                         Three Months Ended     Year Ended
                                         December December  December  December
                                            31,      31,       31,       31,
                                           2008     2007      2008      2007

    Net revenues                          $74,125  $72,517  303,976  $284,332

    Cost of revenues                       20,233   19,127   78,850    75,035

    Gross profit                           53,892   53,390  225,126   209,297

    Operating expenses:
     Sales and marketing                   26,325   26,502  115,062    98,231
     General and administrative            16,249   15,266   62,154    53,280
     Research and development               5,951    6,610   26,165    25,727
     Restructuring                          4,042             6,231         -
     Patients First Program                   -          -      -      (1,796)


    Total operating expenses               52,567   48,378  209,612   175,442


    Profit from operations                  1,325    5,012   15,514    33,855

    Interest and other income (expense),
     net                                     (111)     852    1,562     3,095

    Profit before income taxes               1,214    5,864  17,076    36,950

    Provision for (benefit from) income
     taxes                                (64,282)     196  (62,911)    1,226

    Net profit                            $65,496   $5,668  $79,987   $35,724

    Net profit per share
         - basic                            $0.99    $0.08    $1.20     $0.53
         - diluted                          $0.98    $0.08    $1.18     $0.50

    Shares used in computing net profit
     per share
         - basic    
'/>"/>
SOURCE Align Technology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. MedPredict Publishes Two New Reports Providing Expert Analysis of Malignant Hematology Drug Development
2. A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe
3. Tennessee Hospital Association Selects PivotHealth To Provide Hospital-Physician Alignment Services
4. FDA Clears Expanded Labeling for the Invisalign System
5. Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009
6. Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System
7. Align Technology Announces Third Quarter Fiscal 2008 Results
8. 5- and 10-year survival continues to improve for US children with hematologic malignancies
9. SpectraScience Awarded Patent for Correcting Image Misalignment
10. Align Technology Announces Second Quarter Fiscal 2008 Results
11. Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Summer is here, and with it comes the season ... they can be a pain for dogs. Animal Emergency & ... customers get rid of ticks and prevent them completely. , ... summer, which is why they are so active during this ... areas and carry a number of diseases, including lyme disease, ...
(Date:8/1/2014)... August 01, 2014 As AndroGel lawsuits ... country, Ronald E. Johnson, Jr. has been appointed as ... and other testosterone medications. Since the Fall of 2013, ... have worked diligently to investigate and prosecute the claims ... and blood clots as a result of taking testosterone. ...
(Date:8/1/2014)... benefits of a cancer diagnosis may improve health outcomes ... conducted by a researcher at the University of Houston ... writing intervention is the writing instruction. Otherwise, writing is ... a journal can be therapeutic, but oftentimes we don,t ... or not," said Qian Lu, assistant professor and director ...
(Date:8/1/2014)... 01, 2014 Growing prevalence of ... healthcare reforms are boosting healthcare market growth, although ... discounts and increasing generic consumption is a major ... million in 2013, having grown at a Compound ... The implementation of the Health Transformation Program (Saglikta ...
(Date:8/1/2014)... Hawley, PA (PRWEB) August 01, 2014 Hot ... in the destination spa category of the World’s Best ... kicks off a month-long celebration of National Relaxation Day (technically ... together a series of MAJOR experts to help guests celebrate ... how important it is for health and wellness to carve ...
Breaking Medicine News(10 mins):Health News:Tis the Season for Tick Prevention 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 2Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 3Health News:Turkey Pharmaceutical and Medical Device Market Worth $21.5B & $3.3B by 2020 Respectively, Says a Report Available at MarketOptimizer.org 4Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 2Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 3Health News:The Lodge at Woodloch Kicks Off National Relaxation Day with a Month Long Celebration 4
... traffic pollution may increase respiratory problems and reduce lung ... studied the effects of road and traffic density on ... town of Ciudad Juarez in Mexico. , Our results ... at home or at school, can lead to chronic ...
... 13 The owners of five,separate Miami-based health ... Assistant Attorney General Alice S. Fisher of the ... the Southern District of,Florida announced today. Collectively, the ... $28.6 million worth of unnecessary durable,medical equipment (DME) ...
... Inc. (Nasdaq: ISIS ) announced today that ... orphan drug status to ISIS 333611 for,the treatment ... (ALS),commonly referred to as Lou Gehrig,s disease. ALS ... of muscle control that can,lead to death. ISIS ...
... part of NDA submission in 2009, SYDNEY, Australia, ... of a second Phase III clinical trial for its,lead ... placebo controlled, double blind safety extension trial is,designed to ... the,Company,s submission of a New Drug Application (NDA) to ...
... 13 This year, pack nutrients,into your holiday ... sponsored by Dairy Council of California.,Instead of ... serve lightened-up holiday classics like Candy Cane Cocoa, ... and the bone-building benefits,of calcium, a much-needed nutrient ...
... Mass. and NEW YORK, Dec. 13 Boston,Scientific ... Partners, a leading,private equity firm, today jointly announced ... will acquire from Boston Scientific its Fluid,Management and ... The,transaction is expected to close in the first ...
Cached Medicine News:Health News:Heavy traffic makes breathing a burden in children 2Health News:Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners 2Health News:Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners 3Health News:Medicare Fraud Strike Force Cases Result in Long Prison Terms for Five Health Care Company Owners 4Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 2Health News:Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 3Health News:QRxPharma Initiates Second Phase III Clinical Trial for its 'Dual Opioid' Pain Therapy 2Health News:Seasonal Sippers Supply Bone-Building Benefits 2Health News:Seasonal Sippers Supply Bone-Building Benefits 3Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 2Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 3Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 4Health News:Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million 5
(Date:8/1/2014)... -- Research and Markets  has announced the ... Markets (Lab-Based, Professional POC, Home, Employment, Criminal Justice ... http://photos.prnewswire.com/prnh/20130307/600769 Drugs ... IVD testing with competitive participation by top IVD ... justice personnel, and sports use drug tests as ...
(Date:8/1/2014)... 2014 RoundTable Healthcare Partners ("RoundTable"), an ... healthcare industry, announced today the sale of Vesta ... Lubrizol, a Berkshire Hathaway company, is a specialty ... customers in the global transportation, industrial and consumer ... Vesta is an ISO-13485 certified medical ...
(Date:8/1/2014)... According to the new ... Anti infective), Basic (Films, Cleansing), Advanced (Hydrogels, Hydrocolloids, ... Pressure Relief Devices, NPWT) - Global Forecast to ... is expected to reach $18.3 Billion by 2019 ... CAGR of 3.2% from 2014 to 2019. ...
Breaking Medicine Technology:Drugs of Abuse Testing Markets (Lab-Based, Professional POC, Home, Employment, Criminal Justice Markets) 2RoundTable Healthcare Partners Announces Sale of Vesta Funding, Inc. to The Lubrizol Corporation 2Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
No. 1. 30 mm conventional blades. Thin well-rounded tips....
Aspirating adjustable lid speculum is ideal for cataract and laser refractive procedures....
Open 15 mm blades with lifting wings manipulation of I/A cannulas, knives, instrumentation, etc. Screwlocking mechanism. Dull finish....
Solid 8 mm blades. Dull finish. Most popular size or model....
Medicine Products: